Results from a clinical trial investigating a new T cell receptor (TCR) therapy that uses a person's own immune system to recognize and destroy cancer cells demonstrated a clinical response in 80 percent of multiple myeloma patients with advanced disease after
undergoing autologous stem cell transplants (ASCT).
Not exact matches
Along with the investigational monoclonal antibody, study participants
underwent multi-drug chemotherapy, surgery, radiation and
autologous hematopoietic
stem cell transplantation.
I was diagnosed with non-Hodgkin's diffuse B -
cell lymphoma on Aug. 14, 2015, and since then, I have
undergone three rounds of chemotherapy, 22 radiation treatments and an
autologous stem cell transplant.